Skip to main content
Fig. 1 | BMC Urology

Fig. 1

From: Bone management in Japanese patients with prostate cancer: hormonal therapy leads to an increase in the FRAX score

Fig. 1

The FRAX score with or without ADT in the patients who received brachytherapy. The FRAX score between prostate cancer patients who received brachytherapy with ADT and those without ADT was compared. a According to the 10-year major osteoporotic risk, the ADT group showed a tendency toward a higher FRAX score (p = 0.12). b According to the 10-year hip fracture risk, the ADT group showed a significantly higher FRAX score than the non-ADT group (p = 0.04)

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us